DaVita had its Relative Strength (RS) Rating upgraded from 79 to 83 Friday.
This proprietary rating tracks technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the trailing 52 weeks matches up against the rest of the market.
Over 100 years of market history shows that the top-performing stocks typically have an RS Rating of at least 80 as they begin their biggest climbs.
Risk Management In The Stock Market: How Much Money To Invest Now
DaVita is trying to complete a consolidation with a 179.60 entry. See if it can clear the breakout price in heavy trade.
The company reported 20% earnings growth in the latest quarterly report. Sales increased 5%.
DaVita holds the No. 7 rank among its peers in the Medical-Outpatient/Home Care industry group. Encompass Health, AdaptHealth and Fresenius Medical Care are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
